D Halter

946 total citations
9 papers, 357 citations indexed

About

D Halter is a scholar working on Rheumatology, Epidemiology and Hematology. According to data from OpenAlex, D Halter has authored 9 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 2 papers in Epidemiology and 2 papers in Hematology. Recurrent topics in D Halter's work include Spondyloarthritis Studies and Treatments (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). D Halter is often cited by papers focused on Spondyloarthritis Studies and Treatments (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). D Halter collaborates with scholars based in United States, Netherlands and Belgium. D Halter's co-authors include Kurt de Vlam, C. Birbara, Piet Geusens, Arthur Kavanaugh, Christian Antoni, Cynthia Guzzo, Gerald G. Krueger, Dafna D. Gladman, Anna Beutler and Désirée van der Heijde and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis & Rheumatism.

In The Last Decade

D Halter

8 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Halter United States 5 302 225 160 18 17 9 357
J Brückel United States 6 363 1.2× 175 0.8× 134 0.8× 30 1.7× 11 0.6× 9 393
Sutha Shanmugarajah Canada 8 521 1.7× 531 2.4× 295 1.8× 6 0.3× 75 4.4× 8 641
Steffen Jugl Switzerland 13 312 1.0× 252 1.1× 159 1.0× 2 0.1× 23 1.4× 21 357
D. Ruiz Spain 7 148 0.5× 100 0.4× 44 0.3× 12 0.7× 7 0.4× 29 256
Damiano Currado Italy 7 116 0.4× 116 0.5× 30 0.2× 3 0.2× 16 0.9× 26 186
Michael Rissler Switzerland 7 166 0.5× 253 1.1× 87 0.5× 3 0.2× 106 6.2× 13 297
Soyi Liu Leage United States 7 292 1.0× 345 1.5× 155 1.0× 2 0.1× 94 5.5× 23 407
L. Myasoutova Russia 5 226 0.7× 175 0.8× 60 0.4× 27 1.5× 14 261
M. Sevrain France 7 249 0.8× 313 1.4× 133 0.8× 2 0.1× 103 6.1× 10 387
Samah Ismail Nasef Egypt 7 74 0.2× 63 0.3× 14 0.1× 4 0.2× 11 0.6× 25 139

Countries citing papers authored by D Halter

Since Specialization
Citations

This map shows the geographic impact of D Halter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Halter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Halter more than expected).

Fields of papers citing papers by D Halter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Halter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Halter. The network helps show where D Halter may publish in the future.

Co-authorship network of co-authors of D Halter

This figure shows the co-authorship network connecting the top 25 collaborators of D Halter. A scholar is included among the top collaborators of D Halter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Halter. D Halter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Heijde, Désirée van der, Maxime Bréban, D Halter, et al.. (2014). Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab. Lara D. Veeken. 54(7). 1210–1219. 42 indexed citations
2.
Gómez‐Reino, Juan J., D Halter, Kurt de Vlam, et al.. (2007). Treatment with infliximab is associated with "Major clinical response" in psoriatic arthritis patients treated with infliximab: Analysis of two double-blind placebo controlled trials.. Document Server@UHasselt (UHasselt). 2 indexed citations
3.
Heijde, Désirée van der, Arthur Kavanaugh, Dafna D. Gladman, et al.. (2007). Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis & Rheumatism. 56(8). 2698–2707. 140 indexed citations
4.
Kavanaugh, Arthur, Gerald G. Krueger, Anna Beutler, et al.. (2006). Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial. Annals of the Rheumatic Diseases. 66(4). 498–505. 155 indexed citations
5.
Halter, D, et al.. (1985). Insufficiency os pubis fractures in rheumatoid arthritis.. PubMed. 12(6). 1176–9. 7 indexed citations
6.
Dreux, C, P Passa, & D Halter. (1979). Influence of hepatic insufficiency in pharmacokinetics of drugs: example for an anthranilic diuretic.. PubMed. 1(5). 289–96. 1 indexed citations
7.
Dreux, C & D Halter. (1976). [Spectrofluorometric determination of furosemide in biological fluids. Application to pharmaco- and biokinetic studies].. PubMed. 34(2). 113–20. 3 indexed citations
8.
Dreux, C, Bernard Bousquet, & D Halter. (1974). [Detection and biochemical exploration of carcinoid tumors].. PubMed. 3(11). 671–6.
9.
Dreux, C, Bernard Bousquet, & D Halter. (1973). [Biochemical investigation of carcinoid tumors].. PubMed. 31(4). 283–94. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026